GlassScriptPhysician profile
Douglas R Birns
NPI 1134158488
$3,068.46
in general payments reported to CMS, 2019-2025
22 companies · $218 in 2025
The $218 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $224 · 2021: $382 · 2022: $645 · 2023: $552 · 2024: $645 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,252 · Education: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,251.57 |
| Education | $163.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $492.58 | 2022-2024 | Erleada |
| Astellas Pharma US INC | $475.67 | 2019-2024 | Myrbetriq, Veozah |
| Pfizer INC. | $467.25 | 2019-2024 | |
| Abbvie INC. | $329.80 | 2019-2025 | Lupron Depot |
| Teleflex LLC | $238.52 | 2023-2024 | Urolift |
| Dentsply Ih Ab | $214.89 | 2022-2025 | Lofric, Lofric |
| Boston Scientific Corporation | $156.22 | 2022 | |
| Dendreon Pharmaceuticals LLC | $104.54 | 2021-2023 | Provenge |
| Allergan, INC. | $94.21 | 2019-2020 | |
| Dentsply Ih INC. | $76.85 | 2019-2022 | |
| Olympus America INC. | $67.45 | 2025 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $61.31 | 2022-2024 | |
| Blue Earth Diagnostics | $49.56 | 2021 | |
| Merck Sharp & Dohme LLC | $48.40 | 2020-2024 | Lynparza |
| Novo Nordisk INC | $38.87 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $35.20 | 2019 | |
| Myriad Genetic Laboratories, INC. | $24.41 | 2022 | |
| Myovant Sciences INC. | $22.25 | 2021 | |
| Tolmar, INC. | $20.00 | 2025 | Eligard |
| Progenics Pharmaceuticals, INC. | $19.30 | 2023 | Pylarify |
| Urogen Pharma, INC. | $18.24 | 2025 | |
| Metuchen Pharmaceuticals | $12.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Birns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.